Trial By Error: A Commercial Deal for King ’ s College London ’ s IBS-CBT Digital Program

By David Tuller, DrPH On January 10th, the following information was announced in a press release: Mahana Therapeutics, a digital therapeutics company reimagining the treatment of chronic diseases, today announced that the Company has entered into a licensing and collaboration agreement with King’s College London, a leading research university and one of the oldest and […]

Source: virology blog - January 27, 2020 Category: Virology Authors: David Tuller Tags: David Tuller ME/CFS Source Type: blogs